[1] Frame JD, Baldwin JM Jr, Gocke DJ, Troup JM. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am J Trop Med Hyg 1970;19(4):670 − 6. https://doi.org/10.4269/ajtmh.1970.19.670.
[2] Olayemi A, Cadar D, Magassouba N, Obadare A, Kourouma F, Oyeyiola A, et al. New hosts of the Lassa virus. Sci Rep 2016;6:25280. https://doi.org/10.1038/srep25280.
[3] Kofman A, Choi MJ, Rollin PE. Lassa fever in travelers from West Africa, 1969-2016. Emerg Infect Dis 2019;25(2):245 − 8. https://doi.org/10.3201/eid2502.180836.
[4] Wolf T, Ellwanger R, Goetsch U, Wetzstein N, Gottschalk R. Fifty years of imported Lassa fever: a systematic review of primary and secondary cases. J Travel Med 2020;27(4):taaa035. https://doi.org/10.1093/jtm/taaa035.
[5] Okoro OA, Bamgboye E, Dan-Nwafor C, Umeokonkwo C, Ilori E, Yashe R, et al. Descriptive epidemiology of Lassa fever in Nigeria, 2012-2017. Pan Afr Med J 2020;37:15. https://doi.org/10.11604/pamj.2020.37.15.21160.
[6] Kenmoe S, Tchatchouang S, Ebogo-Belobo JT, Ka'e AC, Mahamat G, Simo REG, et al. Systematic review and meta-analysis of the epidemiology of Lassa virus in humans, rodents and other mammals in sub-Saharan Africa. PLoS Negl Trop Dis 2020;14(8):e0008589. https://doi.org/10.1371/journal.pntd.0008589.
[7] Basha SM, Venugopalaiah P, Chandra YP. A review on Lassa fever. Int J Clin Pharmacokinet Med Sci 2023;3(3):96 − 103. https://doi.org/10.26452/ijcpms.v3i3.542.
[8] Garry RF. Lassa fever — the road ahead. Nat Rev Microbiol 2023;21(2):87 − 96. https://doi.org/10.1038/s41579-022-00789-8.
[9] Tschismarov R, Van Damme P, Germain C, De Coster I, Mateo M, Reynard S, et al. Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trial. Lancet 2023;401(10384):1267 − 76. https://doi.org/10.1016/S0140-6736(23)00048-X.